Colgate-Palmolive India [COLPAL] reported a 9% sales increase in Q4 FY24 to ₹1,582.77 crore, while net profit marginally declined to ₹353 crore, with full-year FY24 revenue reaching ₹6,124 crore.

End-of-day market summary for 2026-05-22

The Indian government has increased its stake sale in Central Bank of India [CENTRALBK] to 8% after the initial offer was oversubscribed 2.36 times by non-retail investors, with retail bidding commencing soon.

A recent report highlights 10 large-cap stocks (excluding BFSI) on the NSE that have demonstrated continuous net sales growth for four consecutive quarters, signalling strong underlying business momentum.

3M India [3MINDIA] has announced a substantial total dividend of ₹506 per share, comprising both a final and special dividend, with July 17 designated as the record date for eligible shareholders, pending AGM approval.

Hindalco Industries [HINDALCO] reported a 51% year-on-year decline in its consolidated net profit for Q4 FY24, reaching ₹2,597 crore, while also recommending a ₹5 dividend per share.

A recent Friday witnessed significant activity in the Indian equities market, with Honasa Consumer Ltd. (Mamaearth) [HONASA] and Life Insurance Corporation of India [LICI] among the top stocks experiencing notable movements.

Eicher Motors, the parent company of Royal Enfield, has reported a strong financial performance for Q4FY26, with consolidated net profit climbing 12% and revenue increasing 16% year-on-year.

IT services giant Wipro Limited [WIPRO] has declared June 5, 2026, as the record date for its massive ₹15,000 crore share buyback program, offering eligible shareholders ₹250 per share.

A strong rally on Friday saw the Sensex close higher, propelling five prominent BSE 100 companies, including Apollo Hospitals and Grasim, to their 52-week high marks, indicating robust investor confidence.

Info Edge India Ltd., the parent company behind leading platforms like Naukri.com, announced a strong finish to FY26 with a 22% year-on-year increase in consolidated net profit and a 16% rise in revenue for the March quarter.

Sun Pharmaceutical Industries Ltd. [SUNPHARMA] has reported a robust 26% year-on-year rise in consolidated net profit for Q4FY26, reaching ₹2,714 crore, while also announcing a dividend of ₹5 per share.

Global research firm Bernstein has initiated comprehensive coverage on six Indian pharmaceutical companies, with Zydus Lifesciences [ZYDUSLIFE] identified as its top choice. The brokerage cites AI-led innovation, niche advancements, and an improved quality culture as major tailwinds for the sector.

Despite the Nifty Microcap 250 index remaining largely stagnant, a select group of microcap stocks, significantly backed by mutual funds, have demonstrated extraordinary performance, with some delivering returns of up to 515% over the past year.

Morgan Stanley has reaffirmed its bullish stance on Tata Group's Titan Company [TITAN], designating it a 'Golden Compounder' with a target price of ₹5,182, despite recent regulatory headwinds.